Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	IPO	Series A Convertible Preferred Stock	Common Stock	Common Stock IPO	Additional Paid-in Capital	Additional Paid-in Capital IPO	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at Dec. 31, 2020	$ 5,169			$ 1		$ 13,343			$ (8,175)
Balance (in shares) at Dec. 31, 2020			7,064,925
Balance at Dec. 31, 2020			$ 55,738
Balance (in shares) at Dec. 31, 2020				11,953,107
Series A convertible preferred stock issuance costs			$ (3)
Issuance of common stock, public offering		$ 152,754			$ 1		$ 152,753
Issuance of common stock, public offering (in shares)					9,823,532
Conversion of Series A convertible preferred stock into common stock	55,735			$ 1		55,734
Conversion of Series A convertible preferred stock into common stock (in shares)			(7,064,925)
Conversion of Series A convertible preferred stock into common stock			$ (55,735)
Conversion of Series A convertible preferred stock into common stock (in shares)				7,064,925
Issuance of restricted stock (in shares)				204,187
Exercise of stock options	254					254
Exercise of stock options, (in shares)				48,663
Purchases under employee stock purchase plan	214					214
Purchases under employee stock purchase plan (in shares)				21,007
Stock-based compensation expense	6,234					6,234
Unrealized gain (loss) on investments, net	(10)							$ (10)
Net loss	(41,567)								(41,567)
Balance at Dec. 31, 2021	178,783			$ 3		228,532		(10)	(49,742)
Balance (in shares) at Dec. 31, 2021				29,115,421
Issuance of restricted stock (in shares)				186,727
Exercise of stock options	516					516
Exercise of stock options, (in shares)				81,067
Purchases under employee stock purchase plan	723					723
Purchases under employee stock purchase plan (in shares)				178,339
Stock-based compensation expense	10,336					10,336
Unrealized gain (loss) on investments, net	9							9
Net loss	(81,828)								(81,828)
Balance at Dec. 31, 2022	108,539			$ 3		240,107		(1)	(131,570)
Balance (in shares) at Dec. 31, 2022				29,561,554
Issuance of common stock, public offering		$ 161,803			$ 1		$ 161,802
Issuance of common stock, public offering (in shares)					5,750,000
Issuance of restricted stock (in shares)				180,316
Exercise of stock options	$ 937					937
Exercise of stock options, (in shares)	125,192			125,192
Purchases under employee stock purchase plan	$ 1,081					1,081
Purchases under employee stock purchase plan (in shares)				249,548
Stock-based compensation expense	14,131					14,131
Unrealized gain (loss) on investments, net	1							$ 1
Net loss	(117,255)								(117,255)
Balance at Dec. 31, 2023	$ 169,237			$ 4		$ 418,058			$ (248,825)
Balance (in shares) at Dec. 31, 2023				35,866,610